Locally Advanced Or Metastatic Solid Tumors With Egfr And Or Her2 Aberrations clinical trials

Explore recruiting locally advanced or metastatic solid tumors with egfr and or her2 aberrations clinical trials.

Also recruiting in Europe

Locally Advanced Or Metastatic Solid Tumors With Egfr And Or Her2 Aberrations trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer

France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Locally Advanced Or Metastatic Solid Tumors With Egfr And Or Her2 Aberrations trials by city

Locally Advanced Or Metastatic Solid Tumors With Egfr And Or Her2 Aberrations in Toronto Locally Advanced Or Metastatic Solid Tumors With Egfr And Or Her2 Aberrations in Vancouver Locally Advanced Or Metastatic Solid Tumors With Egfr And Or Her2 Aberrations in Montreal Locally Advanced Or Metastatic Solid Tumors With Egfr And Or Her2 Aberrations in Calgary Locally Advanced Or Metastatic Solid Tumors With Egfr And Or Her2 Aberrations in Edmonton Locally Advanced Or Metastatic Solid Tumors With Egfr And Or Her2 Aberrations in Ottawa Locally Advanced Or Metastatic Solid Tumors With Egfr And Or Her2 Aberrations in Winnipeg Locally Advanced Or Metastatic Solid Tumors With Egfr And Or Her2 Aberrations in Quebec City Locally Advanced Or Metastatic Solid Tumors With Egfr And Or Her2 Aberrations in Hamilton Locally Advanced Or Metastatic Solid Tumors With Egfr And Or Her2 Aberrations in Kitchener Locally Advanced Or Metastatic Solid Tumors With Egfr And Or Her2 Aberrations in London Locally Advanced Or Metastatic Solid Tumors With Egfr And Or Her2 Aberrations in Halifax Locally Advanced Or Metastatic Solid Tumors With Egfr And Or Her2 Aberrations in New York Locally Advanced Or Metastatic Solid Tumors With Egfr And Or Her2 Aberrations in Los Angeles Locally Advanced Or Metastatic Solid Tumors With Egfr And Or Her2 Aberrations in Chicago Locally Advanced Or Metastatic Solid Tumors With Egfr And Or Her2 Aberrations in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease